ConductScience.org, home

Paper36974661

Current Advances and Future Prospects in Cancer Immunotherapeutics.

Dede Z and 3 others. Medeni Med J, 2023. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Current Advances and Future Prospects in Cancer Immunotherapeutics. Papers, record 36974661. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36974661

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current Advances and Future Prospects in Cancer Immunotherapeutics.
PubMed
Journal
Medeni Med J
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.24
iCite
Revised in PubMed
2023-04-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127000871Advances in personalized cancer immunotherapy.Breast Cancer2017https://conductscience.org/library/papers/27000871PubMed
233818764Cancer statistics for the year 2020: An overview.Int J Cancer2021https://conductscience.org/library/papers/33818764PubMed
333921028mRNA-Based Vaccines.Vaccines (Basel)2021https://conductscience.org/library/papers/33921028PubMed
433859752Turning cold tumors into hot tumors by improving T-cell infiltration.Theranostics2021https://conductscience.org/library/papers/33859752PubMed
527930631CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia.Clin Adv Hematol Oncol2016https://conductscience.org/library/papers/27930631PubMed
631715131Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors.Cancer Cell2019https://conductscience.org/library/papers/31715131PubMed
722258609Clonal evolution in cancer.Nature2012https://conductscience.org/library/papers/22258609PubMed
832698317Monoclonal Antibodies in Cancer Therapy.Antibodies (Basel)2020https://conductscience.org/library/papers/32698317PubMed
922190859Tumor evasion from T cell surveillance.J Biomed Biotechnol2011https://conductscience.org/library/papers/22190859PubMed
1033745426The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer.Endocr Metab Immune Disord Drug Targets2021https://conductscience.org/library/papers/33745426PubMed
1135110735Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.Nature2022https://conductscience.org/library/papers/35110735PubMed
1234522017The tangled history of mRNA vaccines.Nature2021https://conductscience.org/library/papers/34522017PubMed
1321074069Development of ipilimumab: contribution to a new paradigm for cancer immunotherapy.Semin Oncol2010https://conductscience.org/library/papers/21074069PubMed
1433907315Therapeutic cancer vaccines.Nat Rev Cancer2021https://conductscience.org/library/papers/33907315PubMed
1528416815In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.Nat Nanotechnol2017https://conductscience.org/library/papers/28416815PubMed
1635569432Adverse and unconventional reactions related to immune checkpoint inhibitor therapy for cancer.Int Immunopharmacol2022https://conductscience.org/library/papers/35569432PubMed
1730539464Human Monoclonal Antibodies: The Benefits of Humanization.Methods Mol Biol2019https://conductscience.org/library/papers/30539464PubMed
1833859638Cancer Vaccines, Adjuvants, and Delivery Systems.Front Immunol2021https://conductscience.org/library/papers/33859638PubMed
1931754328Current Progress in CAR-T Cell Therapy for Solid Tumors.Int J Biol Sci2019https://conductscience.org/library/papers/31754328PubMed
2035020204Cancer statistics, 2022.CA Cancer J Clin2022https://conductscience.org/library/papers/35020204PubMed

See all 43 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42515758Pharmaceutical Compounding as a Pillar of Personalized Oncology: Current Applications, Emerging Technologies, and Future Perspectives.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515758PubMed
41285444Variations in Cancer with Heart Failure Related Mortality in the United States from 1999-2020.Clin Med Res2025https://conductscience.org/library/papers/41285444PubMed
40059555"I Became the Messenger Between the Hospitals": A Study on the Journeys of People With Cancer Using the Critical Incident Technique.Health Expect2025https://conductscience.org/library/papers/40059555PubMed
39729909Little strokes fell big oaks: The use of weak magnetic fields and reactive oxygen species to fight cancer.Redox Biol2025https://conductscience.org/library/papers/39729909PubMed
39519237GdVO4:Eu3+ and LaVO4:Eu3+ Nanoparticles Exacerbate Oxidative Stress in L929 Cells: Potential Implications for Cancer Therapy.Int J Mol Sci2024https://conductscience.org/library/papers/39519237PubMed
39311156Emerging Cancer Immunotherapies: Cutting-Edge Advances and Innovations in Development.Med Sci (Basel)2024https://conductscience.org/library/papers/39311156PubMed
38853541Role of HIF-1α in the Responses of Tumors to Radiotherapy and Chemotherapy.Cancer Res Treat2025https://conductscience.org/library/papers/38853541PubMed

Download CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36974661

GET https://conductscience.org/api/papers/v1/36974661/references?page=2